Insecticides (India) Ltd Board Approves FY26 Audited Results, New ESOP Scheme
Insecticides (India) Limited approved audited financial results for FY26 and Q4FY26. The Board approved the Employee Stock Purchase Scheme 2026, allowing up to 2,00,000 equity shares. Mrs. Nikunj Aggarwal resigned as Whole Time Director. Mr. Sanskar Aggarwal was appointed Additional Whole Time Director for five years. The 29th AGM is on August 12, 2026.
The approval of the ESOP scheme and changes in directorship, including the appointment of a new Whole Time Director, are significant corporate actions that can impact governance and employee motivation. The audited financial results provide essential performance data for stakeholders.
The announcement includes routine financial results, the approval of an employee stock option plan, and changes in directorship, which are standard corporate actions. No significant positive or negative financial performance or strategic shifts were highlighted.
Insecticides (India) Limited announced the outcome of its Board Meeting held on May 28, 2026. The Board approved the Audited Financial Results for the Quarter and Year ended March 31, 2026, with an unmodified audit opinion from M/s S S Kothari Mehta & Co., LLP and M/s Devesh Parekh & Co.
The Board also approved the formulation of the Employee Stock Purchase Scheme 2026 (IIL ESPS Scheme 2026), which allows for the offer, issuance, and allotment of up to 2,00,000 Equity Shares of face value Rs. 10 each. These shares will be subject to a one-year lock-in period from the date of allotment and will also be available to employees of subsidiary companies. The scheme requires shareholder approval at the upcoming 29th Annual General Meeting (AGM).
In terms of personnel changes, the Board took note of the resignation of Mrs. Nikunj Aggarwal as Whole Time Director. Subsequently, Mr. Sanskar Aggarwal was appointed as an Additional Whole Time Director for a term of five years, effective May 28, 2026, until May 27, 2031. He was also appointed as an Additional Director in the wholly-owned subsidiary, Kaeros Research Limited. Additionally, Mr. Atul Kumar was appointed as Vice President - Sales (North), a Senior Management Personnel (SMP), effective May 28, 2026. The Board also approved the appointment of M/s. T Jain & Associates as Internal Auditors for a five-year term from April 1, 2026, to March 31, 2031.
The 29th Annual General Meeting (AGM) of the Company is scheduled to be held on Wednesday, August 12, 2026, at 03:00 PM through Video Conferencing (VC). The Board meeting commenced at 01:00 PM (IST) and concluded at 04:15 PM (IST).
What to do with a filing like this
Insecticides (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Insecticides (India) Limited. Read the original for the full detail.